Identification of inhibitors for vascular endothelial growth factor receptor by using dynamic combinatorial chemistry

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

The novel analysis method consisting of size-exclusion chromatography (SEC) and HRMS analysis was firstly applied in the discovery of potential inhibitors towards cancer drug targets. With vascular endothelial growth factor receptor (VEGFR-2) as a target, dynamic combinatorial libraries (DCLs) were prepared by reacting aldehydes with amines. Four sensitive binders targeted VEGFR-2 were directly isolated from the library. Antitumor activity test in vitro and inhibition experiments toward angiogenesis were also carried out.

Knowledge Graph

Similar Paper

Identification of inhibitors for vascular endothelial growth factor receptor by using dynamic combinatorial chemistry
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach
Bioorganic & Medicinal Chemistry Letters 2013.0
Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments
Bioorganic & Medicinal Chemistry Letters 2021.0
Discovery of novel picolinamide-based derivatives as novel VEGFR-2 kinase inhibitors: synthesis,in vitrobiological evaluation and molecular docking
MedChemComm 2018.0
Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines
Journal of Medicinal Chemistry 2018.0
Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents
Bioorganic & Medicinal Chemistry 2013.0
Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach
Genomics & Informatics 2021.0
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
Journal of Medicinal Chemistry 2016.0
Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies
Bioorganic & Medicinal Chemistry 2015.0
Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
ACS Medicinal Chemistry Letters 2010.0